May 10, 2022 / 03:40PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good morning, everyone. Welcome to the 2022 Bank of America Healthcare Conference live from beautiful Las Vegas. Thanks, everybody, for being here. Good to see so many people in person again.
Our next company up presenting -- by the way, I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst. Thanks, in case you don't know me. Our next company is 10x Genomics. With us is Serge Saxonov, Co-Founder and CEO; and Justin McAnear, CFO.
Gentlemen, thank you for being here.
Serge Saxonov - 10x Genomics, Inc. - Co-Founder, CEO & Director
Thanks for having us [live here].
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo when we did the -- when we did the IPO a few years ago, I mean 10x was certainly -- having been in the lab for so long, I mean, certainly, the appeal of 10x and, I think, a sense of biology sort of really spoke to the scientist in me.